Experts inform India's debut intranasal vaccine iNCOVACC will be a gamechanger https://ift.tt/ZFub302

Developed by Bharat Biotech, iNCOVACC has been approved as a booster dose for adults across India. Experts suggest that it will be a game changer for India's pharmaceutical industry and humanity's fight against COVID. Since the vaccine is delivered via the nose, right where the virus enters the body, it has the potential to block infection and break the cycle of transmission, as well as prevent lung damage.

from Top Health News | Latest Health & Healthcare Industry Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/YjnhWbF